Eva Riedl

912 total citations
10 papers, 456 citations indexed

About

Eva Riedl is a scholar working on Physiology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eva Riedl has authored 10 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Organic Chemistry and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eva Riedl's work include Biochemical effects in animals (9 papers), Free Radicals and Antioxidants (6 papers) and Diet, Metabolism, and Disease (4 papers). Eva Riedl is often cited by papers focused on Biochemical effects in animals (9 papers), Free Radicals and Antioxidants (6 papers) and Diet, Metabolism, and Disease (4 papers). Eva Riedl collaborates with scholars based in Germany, Netherlands and Austria. Eva Riedl's co-authors include Benito Yard, Frederick Pfister, Hans‐Peter Hammes, Bart Janssen, Margarita Braunagel, Verena Peters, Jacob van den Born, Bernhard K. Krämer, Stephan J. L. Bakker and Gerjan Navis and has published in prestigious journals such as Diabetes, Clinica Chimica Acta and Nephrology Dialysis Transplantation.

In The Last Decade

Eva Riedl

9 papers receiving 450 citations

Peers

Countries citing papers authored by Eva Riedl

Since Specialization

Citations

This map shows the geographic impact of Eva Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Riedl more than expected).

Fields of papers citing papers by Eva Riedl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Riedl. The network helps show where Eva Riedl may publish in the future.

Co-authorship network of co-authors of Eva Riedl

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Riedl. A scholar is included among the top collaborators of Eva Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Riedl. Eva Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Raumbegehren 2017 ·Peter Lang D eBooks ·Eva Riedl	0
2	Carnosine treatment in combination with ACE inhibition in diabetic rats 2014 ·Regulatory Peptides ·Verena Peters, Eva Riedl, Margarita Braunagel, (unknown), Sibylle J. Hauske, Frederick Pfister, Johannes Zschocke, (unknown), Urs Benck, Hans‐Peter Hammes, Bernhard K. Krämer, (unknown), Benito Yard, Hannes Köppel	35
3	Different conformational forms of serum carnosinase detected by a newly developed sandwich ELISA for the measurements of carnosinase concentrations 2012 ·Amino Acids ·(unknown), (unknown), Eva Riedl, (unknown), Frederick Pfister, Verena Peters, Claus Peter Schmitt, (unknown), (unknown), (unknown), Gerjan Navis, Jacob van den Born, Stephan J. L. Bakker, Bernhard K. Krämer, Benito Yard, Sibylle J. Hauske	20
4	Carnosine Prevents Apoptosis of Glomerular Cells and Podocyte Loss in STZ Diabetic Rats 2011 ·Cellular Physiology and Biochemistry ·Eva Riedl, Frederick Pfister, Margarita Braunagel, Paul Brinkkötter, (unknown), (unknown), Stephan J. L. Bakker, Robert H. Henning, Jacob van den Born, Bernhard K. Krämer, Gerjan Navis, Hans‐Peter Hammes, Benito Yard, (unknown)	98
5	L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF- production and signalling 2011 ·Nephrology Dialysis Transplantation ·Hannes Köppel, Eva Riedl, Margarita Braunagel, (unknown), Sabrina Ehnert, Patrício Godoy, (unknown), Steven Dooley, Benito Yard	31
6	Oral Carnosine Supplementation Prevents Vascular Damage in Experimental Diabetic Retinopathy 2011 ·Cellular Physiology and Biochemistry ·Frederick Pfister, Eva Riedl, Qian Wang, Franziska vom Hagen, (unknown), Martin C. Harmsen, Grietje Molema, Benito Yard, Yuxi Feng, Hans‐Peter Hammes	92
7	Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration 2010 ·Clinica Chimica Acta ·Verena Peters, Erwin E. W. Jansen, Cornelis Jakobs, Eva Riedl, Bart Janssen, Benito Yard, Johannes Wedel, Georg F. Hoffmann, Johannes Zschocke, Daniel Gotthardt, Christine Fischer, Hannes Köppel	46
8	N-Glycosylation of Carnosinase Influences Protein Secretion and Enzyme Activity 2010 ·Diabetes ·Eva Riedl, (unknown), Frederick Pfister, Verena Peters, (unknown), (unknown), Paul T. Brinkkoetter, Hanswalter Zentgraf, Gerjan Navis, Robert H. Henning, Jacob van den Born, Stephan J. L. Bakker, Bart Janssen, Fokko J. van der Woude, Benito Yard	36
9	Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity 2009 ·Amino Acids ·Verena Peters, (unknown), (unknown), Cornelis Jakobs, Eva Riedl, (unknown), (unknown), (unknown), (unknown), Matthias Mack, Georg F. Hoffmann, Bart Janssen, Johannes Zschocke, Benito Yard	39
10	A CTG Polymorphism in the CNDP1 Gene Determines the Secretion of Serum Carnosinase in Cos-7–Transfected Cells 2007 ·Diabetes ·Eva Riedl, (unknown), Paul T. Brinkkoetter, (unknown), Herbert Steinbeißer, (unknown), Bart Janssen, Fokko J. van der Woude, Benito Yard	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact